Sutro Biopharma, Inc. (STRO)
18.16
-0.26
(-1.41%)
USD |
NASDAQ |
Feb 23, 16:00
18.16
0.00 (0.00%)
After-Hours: 19:59
Sutro Biopharma SG&A Expense (Quarterly) : 8.741M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| GT Biopharma, Inc. | 2.748M |
| Rhythm Pharmaceuticals, Inc. | 52.42M |
| Crinetics Pharmaceuticals, Inc. | 52.26M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |